IQVIA HOLDINGS INC
IQVNYSETrading Snapshot
- Day Range
- $266.27 – $270.40
- 52-Week Range
- $154.50 – $277.40
- Volume
- $2.86B
- Avg Volume
- $2.16B
- Shares Outstanding
- 164.6M
- Next Earnings
- Nov 17, 2026
Fundamentals Snapshot
- Annual Revenue
- $16.31B
- Last Q Revenue
- $4.37B
- P/E Ratio
- 33.3
- P/S Ratio
- 2.6x
- EPS (TTM)
- $8.22
- Dividend Yield
- 0.00%
- Dilution (1yr)
- −4.9%
Why Investors Own IQV
- ✓High-growth profile — revenue up +16.5% YoY with expanding US Equity exposure.
- ✓Healthy economics — 37% gross margin and 6% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
IQVIA HOLDINGS INC
IQV
StockOtter · stockotter.spaceAbout IQVIA HOLDINGS INC
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
Rep. Kevin Hern Unloads Shares of Honeywell International Inc. (NASDAQ:HON)
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Honeywell International Inc. (NASDAQ: HON). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $15,001
Crane (NYSE:CR) Stock Sold Off by Rep. Kevin Hern
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Crane (NYSE: CR). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $50,001 and $100,000 in Crane sto
Colgate-Palmolive (NYSE:CL) Stock Sale Revealed by Rep. Kevin Hern
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Colgate-Palmolive Company (NYSE: CL). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $1,001 and $1
Walmart (NASDAQ:WMT) Shares Unloaded by Rep. Kevin Hern
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Walmart Inc. (NASDAQ: WMT). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $1,001 and $15,000 in W
Novo Nordisk A/S (NYSE:NVO) Stock Sold Off by Rep. Kevin Hern
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Novo Nordisk A/S (NYSE: NVO). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $1,001 and $15,000 in
Rep. Kevin Hern Sells Shares of Devon Energy Corporation (NYSE:DVN)
Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Devon Energy Corporation (NYSE: DVN). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $15,001 and $